Moderna said on Friday the European Patent Office had upheld the validity of one of the company's key patents, a win in an ongoing COVID-19 vaccine dispute with Pfizer and BioNTech .

Moderna Inc must face a patent infringement lawsuit over its COVID-19 vaccines, a federal judge in Delaware ruled Wednesday, finding that the biotech company has not shown that the U.S. government ...

Pfizer and its German partner BioNTech asked London's Court of Appeal on Thursday to overturn a ruling that their COVID-19 ...

The news sent shares in Moderna down 9% despite it being unclear whether the patent is relevant to its COVID-19 vaccine. The case centers on an Arbutus patent covering lipid formulations for the ...

Moderna and Pfizer/BioNTech earned more than $110 billion from their COVID vaccines. Read how patent infringement cases could impact their respective businesses.

Moderna may be at risk of infringement lawsuits over its COVID-19 vaccine after losing a federal appeal over patents from a rival drugmaker, Bloomberg reported. The U.S. Court of Appeals for the ...

Moderna said on May 17 that the European Patent Office had upheld the validity of one of the company’s key patents, a win in an ongoing Covid-19 vaccine dispute with Pfizer and BioNTech.. The ...

Moderna said on Friday (May 17) the European Patent Office had upheld the validity of one of the company's key patents, a win in an ongoing Covid-19 vaccine dispute with Pfizer and BioNTech.

London: Moderna has won a case at the European Patent Office against Pfizer and BioNTech in a dispute over its COVID-19 vaccine, the company said on Friday. The vaccine maker has been locked in an ...